Finance

Are Financial Incentives Hindering Personalized Healthcare Overhaul?
Care Are Financial Incentives Hindering Personalized Healthcare Overhaul?

The U.S. healthcare system faces a significant challenge: balancing financial incentives with the need for personalized patient care. Although financial incentives are critical for the sustainability of healthcare institutions, they often conflict with the goal of providing individualized

Healthcare M&A Faces Slowdown Amid Growing Antitrust Scrutiny
Business Healthcare M&A Faces Slowdown Amid Growing Antitrust Scrutiny

The healthcare sector, once a bustling hive of mergers and acquisitions (M&A) driven by private equity (PE) investment, is experiencing a marked deceleration. This slowdown is largely attributable to growing antitrust scrutiny from federal and state regulators, creating an environment of

How Will Chile’s New Law Reshape Private Healthcare Insurers?
Business How Will Chile’s New Law Reshape Private Healthcare Insurers?

The recent legislative decision by the Chilean Congress marks a significant shift for the country's private healthcare system, specifically targeting the private insurers known as Isapres. The bill, designed to support the struggling sector, includes a mandate that these insurers must

Why Are Trust and Vendor Partnerships Crucial in Healthcare Tech?
Business Why Are Trust and Vendor Partnerships Crucial in Healthcare Tech?

Healthcare technology is advancing rapidly, offering innovative solutions that can revolutionize patient care and streamline operations. However, one critical factor stands at the forefront of successfully integrating these technologies: trust. Trust in vendors, the technology itself, and the data

Improving Billing Practices to Retain Patients and Boost Revenue
Business Improving Billing Practices to Retain Patients and Boost Revenue

In the competitive world of healthcare, the patient experience extends beyond the examination room. One critical, yet often overlooked aspect is the billing experience. While medical practitioners focus primarily on the quality of care, the final interactions that patients often remember are

Can Lenmeldy’s High Cost Be Justified by Its Life-Saving Benefits?
Care Can Lenmeldy’s High Cost Be Justified by Its Life-Saving Benefits?

Gene therapy has ushered in a new era of medical possibilities, offering groundbreaking treatments for debilitating and often fatal diseases. One of the most prominent examples is Lenmeldy (atidarsagene autotemcel), a gene therapy developed by Orchard Therapeutics and recently acquired by Kyowa

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later